14 completed, 4 active not recruiting, 4 terminated, 2 unknown. 25 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 25 | Completed 14, Active not recruiting 4, Terminated 4, Unknown 2, Not yet recruiting 1 |
| Phase 3 | 3 | Completed 2, Unknown 1 |
Follow ASA: new trials by email Literature Review of ASA trials Research Report on ASA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency Enoxaparin, Aspirin - Pregnancy Related, Protein S Deficiency | Phase 2 | Not yet recruiting | Peking University People's Hospital | 48 | 2024-08-01 | 2024-08-01 |
| Outpatient Liquid Aspirin (OLA) ASA - Covid19 | Phase 2 | Unknown | Louisiana State University Health Sciences Center in New Orleans | 200 | 2021-12-06 | 2022-01-03 |
| Effects of Edoxaban on Platelet Aggregation ASA, Clopidogrel, Edoxaban - SCAD, AMI | Phase 2 / Phase 3 | Completed | University of Sao Paulo | 61 | 2021-09-14 | 2025-04-27 |
| Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery EC Aspirin, Radical Prostatectomy, Recombinant Interferon Alfa-2b - Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 | Phase 2 | Active not recruiting | Roswell Park Cancer Institute | 12 | 2019-11-29 | 2026-06-09 |
| Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma Aspirin 81 mg, Aspirin 325mg, Placebo oral tablet - Melanoma (Skin) | Phase 2 | Completed | University of Utah | 95 | 2019-07-25 | 2022-02-18 |
| Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma Rivaroxaban, ASA - Multiple Myeloma in Relapse, Multiple Myeloma Progression | Phase 2 / Phase 3 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 57 | 2019-01-17 | 2024-02-29 |
| ASA in Prevention of Ovarian Cancer (STICs and STONEs) Acetylsalicylic acid, Placebo - Ovarian Cancer Prevention | Phase 2 | Active not recruiting | Canadian Cancer Trials Group | 117 | 2018-07-24 | 2026-09-16 |
| Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Aspirin, Biospecimen Collection, Placebo Administration - Colorectal Adenoma, Colorectal Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 81 | 2018-01-16 | 2026-11-13 |
| A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients ASA, MET, Placebo - Tertiary Prevention in Colon Cancer | Phase 2 | Terminated | Ente Ospedaliero Ospedali Galliera | 160 | 2017-03-15 | 2025-01-27 |
| The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV AOP2014, Phlebotomies, ASA - Polycythemia Vera | Phase 2 | Completed | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | 127 | 2017-02-02 | 2024-09-19 |
| Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma Aspirin 81 mg, Aspirin 325mg - Melanoma (Skin) | Phase 2 | Completed | University of Utah | 41 | 2016-09-27 | 2022-02-18 |
| Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation Aspirin, Laboratory Biomarker Analysis, Placebo Administration - Barrett Esophagus, Esophageal Adenocarcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 21 | 2016-01-15 | 2026-11-13 |
| Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers Aspirin, Laboratory Biomarker Analysis, Placebo Administration - Tobacco Use Disorder | Phase 2 | Completed | National Cancer Institute (NCI) | 63 | 2016-01-13 | 2022-06-02 |
| Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy Aspirin, Laboratory Biomarker Analysis, Metformin Hydrochloride - Recurrent Prostate Carcinoma, Stage I Prostate Cancer | Phase 2 | Terminated | Rutgers, The State University of New Jersey | 27 | 2015-06-23 | 2023-02-08 |
| Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules Aspirin, Laboratory Biomarker Analysis, Placebo - Current Smoker, Former Smoker | Phase 2 | Completed | National Cancer Institute (NCI) | 109 | 2014-11-21 | 2020-05-21 |
| Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. Acetylsalicylic Acid, Placebo - Small for Gestational Age, Infant, Very Low Birth Weight | Phase 2 | Completed | CHU de Quebec-Universite Laval | 50 | 2014-11-01 | 2018-11-09 |
| Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers Aspirin, Laboratory Biomarker Analysis, Placebo - Lung Carcinoma, Tobacco Use Disorder | Phase 2 | Completed | National Cancer Institute (NCI) | 54 | 2014-06-01 | 2018-08-29 |
| The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man Clopidogrel, Ticagrelor, ASA - Acute Coronary Syndrome | Phase 2 | Completed | Medical University of Vienna | 89 | 2010-10-01 | 2014-04-22 |
| Omega-3 and Aspirin in Periodontal Regeneration Regenerative therapy (omega 3 PUFA plus low dose aspirin), Sugar pill - Periodontal Disease | Phase 2 | Completed | October 6 University | 40 | 2009-11-01 | 2010-05-14 |
| Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Aspirin, Eflornithine, Laboratory Biomarker Analysis - Adenomatous Polyp | Phase 2 | Completed | National Cancer Institute (NCI) | 107 | 2009-08-20 | 2019-09-04 |
Showing 20 of 25. Sign in to see all of them.
Colorectal Neoplasms (3) · Tobacco Use Disorder (3) · Colonic Neoplasms (2) · Melanoma (2) · Myocardial Infarction (2) · Prostatic Neoplasms (2) · Acute Coronary Syndrome (1) · Adenocarcinoma Of Esophagus (1) · Adenomatous Polyps (1) · Angina, Stable (1) · Barrett Esophagus (1) · COVID-19 (1) · Coronary Artery Disease (1) · Fetal Growth Retardation (1) · Glioblastoma (1)
National Cancer Institute (NCI) (7) · M.D. Anderson Cancer Center (2) · University of Utah (2) · AstraZeneca (1) · CHU de Quebec-Universite Laval (1) · Canadian Cancer Trials Group (1) · Ente Ospedaliero Ospedali Galliera (1) · FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Louisiana State University Health Sciences Center in New Orleans (1) · Medical University of Vienna (1) · Northwestern University (1) · October 6 University (1) · Peking University People's Hospital (1) · Roswell Park Cancer Institute (1)
United States (16) · Canada (4) · Italy (3) · Australia (1) · Austria (1) · Brazil (1) · China (1) · Egypt (1) · United Kingdom (1)
Douglas Grossman, MD (2) · Amit Oza (1) · Amr M. Elkhouli, ph.D (1) · Andrea De Censi, MD (1) · Bernardo Bonanni (1) · Biren Saraiya, MD (1) · Emmanuel Bujold, MD,MSc,FRCSC (1) · Frank A Sinicrope (1) · Gurkamal S Chatta (1) · Hemant Roy (1) · Linda Garland (1) · Linda L Garland (1) · Mark J Alberts, MD (1) · Martha Louzada, MD (1) · Paul Gurbel, MD (1)
PMID 15189396, PMID 15842354, PMID 18094721, PMID 19923168, PMID 20620737, PMID 20637084, PMID 21079055, PMID 22212857, PMID 22409262, PMID 22795280, PMID 23903204, PMID 26503631, PMID 26986753, PMID 29948566, PMID 30514262, PMID 32678292, PMID 33476571, PMID 34582035, PMID 37489818, PMID 38320126, PMID 40034042
P30CA016672 (3), N01CN00031 (2), N01CN00034 (2), P30CA023074 (2), 2015 (1), N01CN00035 (1), N01CN35157 (1), P30CA015083 (1), P30CA060553 (1), P30CA072720 (1), R01CA113681 (1)